- Home
- MRNA vs ES Comparison
MRNA vs ES Comparison
Compare MRNA & ES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRNA | ES |
|---|---|---|
| Founded | 2010 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6B | 25.1B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | MRNA | ES |
|---|---|---|
| Price | $63.32 | $69.40 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 12 | 11 |
| Target Price | $34.27 | ★ $71.00 |
| AVG Volume (30 Days) | ★ 6.0M | 2.5M |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 4.58% |
| EPS Growth | 21.77 | ★ 100.88 |
| EPS | N/A | ★ 1.61 |
| Revenue | ★ $19,263,000,000.00 | $13,547,244,000.00 |
| Revenue This Year | $9.36 | N/A |
| Revenue Next Year | $15.43 | $3.77 |
| P/E Ratio | ★ N/A | $43.07 |
| Revenue Growth | 4.29 | ★ 13.83 |
| 52 Week Low | $22.28 | $61.53 |
| 52 Week High | $67.74 | $76.41 |
Technical Indicators
Market Signals| Indicator | MRNA | ES |
|---|---|---|
| Relative Strength Index (RSI) | 75.16 | 52.84 |
| Support Level | $45.69 | $66.23 |
| Resistance Level | N/A | $70.89 |
| Average True Range (ATR) | 3.88 | 1.60 |
| MACD | 1.81 | 0.07 |
| Stochastic Oscillator | 85.43 | 61.59 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About ES Eversource Energy (D/B/A)
Eversource Energy is a diversified holding company with subsidiaries that provide rate-regulated electric, gas, and water distribution service to more than 4 million customers in the Northeast US. Eversource expanded its service territories with acquisitions of NStar (2012), Aquarion (2017), and Columbia Gas (2020). In 2024 Eversource exited its 50% partnership with European utility Orsted to develop 2 gigawatts of offshore wind projects in the Northeast US. It plans to sell Aquarion in 2026. The company exited most of its unregulated businesses in 2006.